Home/Filings/4/0001181431-11-001549
4//SEC Filing

KESSEL MARK 4

Accession 0001181431-11-001549

CIK 0000908259other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 9:49 PM ET

Size

6.2 KB

Accession

0001181431-11-001549

Insider Transaction Report

Form 4
Period: 2011-01-02
KESSEL MARK
Director10% Owner
Transactions
  • Award

    Common Stock, $0.01 par value per share

    2011-01-02$0.23/sh+25,000$5,750115,000 total
Holdings
  • Common Stock, $0.01 par value per share

    (indirect: By LLC)
    27,117,118
Footnotes (2)
  • [F1]Mr. Kessel received shares of OXiGENE, Inc. common stock (the "Shares") pursuant to the OXiGENE, Inc. Amended and Restated Director Compensation Policy for Board of Directors services to be provided during the first six months of 2011. The closing price per share on December 31, 2010, the last trading day prior to the grant date for the Shares issued, was $0.23.
  • [F2]Shares are held by Symphony ViDA Holdings LLC. Mr. Kessel is a Managing Member of of Symphony GP LLC, which is the general partner of Symphony Capital GP, L.P., which is the general partner of Symphony Capital Partners, L.P., which is the manager of Symphony ViDA Holdings LLC.

Issuer

OXIGENE INC

CIK 0000908259

Entity typeother

Related Parties

1
  • filerCIK 0001222013

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 9:49 PM ET
Size
6.2 KB